Reaction
Autoinflammatory Disease reporting signals
As of the last recalculation, Autoinflammatory Disease appears in 204 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 544.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canakinumab | 45 | 544.2 | 546.5 |
| Anakinra | 54 | 451.3 | 452.8 |
| Baricitinib | 10 | 111.2 | 111.3 |
| Colchicine | 25 | 110.2 | 110.3 |
| Tofacitinib Citrate | 11 | 90.4 | 90.5 |
| Acetylcysteine | 8 | 90.1 | 90.2 |
| Desloratadine | 9 | 89.5 | 89.6 |
| Daspone | 8 | 87.2 | 87.3 |
| Dapsone Gel, 5% | 8 | 87.2 | 87.2 |
| Dapsone | 8 | 79.5 | 79.6 |
| Cladribine | 7 | 76.9 | 77.0 |
| Oseltamivir | 5 | 65.7 | 65.7 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 3 | 36.4 | 36.4 |